PubRank

Andrew C Larson

Author PubWeight™ 86.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010 1.56
2 Automated rectilinear self-gated cardiac cine imaging. Magn Reson Med 2004 1.52
3 Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol 2007 1.45
4 Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging. Radiology 2007 1.32
5 Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 2005 1.32
6 Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol 2008 1.29
7 A dual-projection respiratory self-gating technique for whole-heart coronary MRA. J Magn Reson Imaging 2008 1.24
8 A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol 2007 1.23
9 MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model. Radiology 2010 1.22
10 Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 2007 1.20
11 Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol 2008 1.19
12 Respiratory self-gated four-dimensional coronary MR angiography: a feasibility study. Magn Reson Med 2008 1.15
13 Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol 2006 1.15
14 Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats. Am J Transl Res 2010 1.13
15 MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiology 2008 1.11
16 Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones. Radiology 2010 1.11
17 Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors. J Vasc Interv Radiol 2007 1.10
18 Diffusion-weighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits. J Magn Reson Imaging 2008 1.08
19 Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol 2007 1.07
20 Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol 2008 1.03
21 Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 2007 1.02
22 Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology 2010 1.01
23 In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006 1.00
24 Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results. J Vasc Interv Radiol 2008 1.00
25 Four-dimensional transcatheter intraarterial perfusion (TRIP)-MRI for monitoring liver tumor embolization in VX2 rabbits. Magn Reson Med 2008 0.96
26 Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 2006 0.96
27 Extraction of the magnetohydrodynamic blood flow potential from the surface electrocardiogram in magnetic resonance imaging. Med Biol Eng Comput 2008 0.96
28 Rabbit VX2 tumors as an animal model of uterine fibroids and for uterine artery embolization. J Vasc Interv Radiol 2007 0.96
29 4D radial coronary artery imaging within a single breath-hold: cine angiography with phase-sensitive fat suppression (CAPS). Magn Reson Med 2005 0.95
30 Magnetization transfer MRI in pancreatic cancer xenograft models. Magn Reson Med 2011 0.95
31 Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol 2010 0.95
32 Multishot diffusion-weighted SPLICE PROPELLER MRI of the abdomen. Magn Reson Med 2008 0.95
33 Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging 2010 0.94
34 Cardiac phase-resolved blood oxygen-sensitive steady-state free precession MRI for evaluating the functional significance of coronary artery stenosis. Invest Radiol 2007 0.94
35 Rapid 3D radiofrequency field mapping using catalyzed double-angle method. NMR Biomed 2009 0.93
36 Contrast-enhanced 4D radial coronary artery imaging at 3.0 T within a single breath-hold. Magn Reson Med 2005 0.92
37 The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 2005 0.91
38 Comparison of self-gated cine MRI retrospective cardiac synchronization algorithms. J Magn Reson Imaging 2008 0.90
39 Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology 2014 0.90
40 Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int J Nanomedicine 2013 0.89
41 Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model. Invest Radiol 2012 0.89
42 Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model. Radiology 2014 0.89
43 Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. AJR Am J Roentgenol 2011 0.89
44 MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model. Invest Radiol 2013 0.88
45 Modified PROPELLER approach for T2-mapping of the abdomen. Magn Reson Med 2009 0.88
46 Respiratory self-gating for free-breathing abdominal phase-contrast blood flow measurements. J Magn Reson Imaging 2009 0.88
47 Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia. Adv Healthc Mater 2013 0.88
48 MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization. J Vasc Interv Radiol 2008 0.87
49 Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors. ACS Nano 2013 0.87
50 Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization. J Vasc Interv Radiol 2010 0.87
51 Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2015 0.87
52 Modification of embolic-PVA particles with MR contrast agents. Magn Reson Med 2008 0.86
53 Quantitative magnetization transfer MRI of desmoplasia in pancreatic ductal adenocarcinoma xenografts. NMR Biomed 2013 0.86
54 Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors. J Vasc Interv Radiol 2011 0.86
55 Feasibility of blood oxygenation level-dependent MR imaging to monitor hepatic transcatheter arterial embolization in rabbits. J Vasc Interv Radiol 2005 0.85
56 Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors. J Magn Reson Imaging 2009 0.85
57 Improved R2* measurement accuracy with absolute SNR truncation and optimal coil combination. NMR Biomed 2010 0.85
58 Determination of optimal gadolinium concentration using SSFP for catheter-directed contrast-enhanced coronary MR angiography. Acad Radiol 2005 0.84
59 Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer. Int J Nanomedicine 2013 0.84
60 Development of a VX2 pancreatic cancer model in rabbits: a pilot study. J Vasc Interv Radiol 2009 0.84
61 Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model. Magn Reson Imaging 2011 0.84
62 Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation. Nanomedicine (Lond) 2013 0.84
63 High-resolution steady-state free precession coronary magnetic resonance angiography within a breath-hold: parallel imaging with extended cardiac data acquisition. Magn Reson Med 2005 0.84
64 MRI of prostate stem cell antigen expression in prostate tumors. Nanomedicine (Lond) 2012 0.83
65 MR imaging- versus conventional X-ray fluoroscopy-guided renal angioplasty in swine: prospective randomized comparison. Radiology 2006 0.83
66 Targeted single-shot methods for diffusion-weighted imaging in the kidneys. J Magn Reson Imaging 2011 0.83
67 Respiratory self-gated multiple gradient recalled echo sequence for free-breathing abdominal R2* mapping. Magn Reson Med 2011 0.83
68 Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints. AJR Am J Roentgenol 2011 0.82
69 Quantitative dual energy CT measurements in rabbit VX2 liver tumors: Comparison to perfusion CT measurements and histopathological findings. Eur J Radiol 2011 0.82
70 MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol 2012 0.82
71 Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma. Acad Radiol 2011 0.81
72 High resolution MRI for non-invasive mouse lymph node mapping. J Immunol Methods 2013 0.81
73 MRl of prostate cancer antigen expression for diagnosis and immunotherapy. PLoS One 2012 0.81
74 Quantitative multiparametric PROPELLER MRI of diethylnitrosamine-induced hepatocarcinogenesis in wister rat model. J Magn Reson Imaging 2010 0.80
75 Characterizing the host response to rhBMP-2 in a rat spinal arthrodesis model. Spine (Phila Pa 1976) 2013 0.80
76 Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis. Magn Reson Imaging 2013 0.80
77 Multishot targeted PROPELLER magnetic resonance imaging: description of the technique and initial applications. Invest Radiol 2009 0.80
78 Seven-tesla magnetic resonance imaging accurately quantifies intratumoral uptake of therapeutic nanoparticles in the McA rat model of hepatocellular carcinoma: preclinical study in a rodent model. Invest Radiol 2014 0.79
79 Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI. AJR Am J Roentgenol 2012 0.79
80 Real-time MRI monitoring of transcatheter hepatic artery contrast agent delivery in rabbits. Acad Radiol 2005 0.79
81 Fast four-dimensional coronary MR angiography with k-t GRAPPA. J Magn Reson Imaging 2008 0.79
82 Invasive catheterization of the hepatic artery for preclinical investigation of liver-directed therapies in rodent models of liver cancer. Am J Transl Res 2013 0.79
83 T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla. Future Oncol 2013 0.79
84 Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol 2008 0.78
85 Imaging tumor response following liver-directed intra-arterial therapy. Abdom Imaging 2013 0.78
86 Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model. J Magn Reson Imaging 2010 0.78
87 Use of a combined MR imaging and interventional radiology suite for intraprocedural monitoring of uterine artery embolization. J Vasc Interv Radiol 2007 0.78
88 MR imaging assessment of changes in renal function with renal artery stent placement in swine. J Vasc Interv Radiol 2007 0.78
89 Quantitative magnetic resonance imaging in the transgenic APC(Δ468) mouse model of hereditary colon cancer. Mol Imaging 2013 0.77
90 Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology 2014 0.77
91 Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors. J Magn Reson Imaging 2011 0.75
92 Targeted radiofrequency field mapping using 3D reduced field-of-view-catalyzed double-angle method. Magn Reson Imaging 2011 0.75
93 Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine (Baltimore) 2017 0.75
94 GESFIDE-PROPELLER approach for simultaneous R2 and R2* measurements in the abdomen. Magn Reson Imaging 2013 0.75
95 Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model. Radiology 2012 0.75
96 k-TE generalized autocalibrating partially parallel acquisition (GRAPPA) for accelerated multiple gradient-recalled echo (MGRE) R2* mapping in the abdomen. Magn Reson Med 2009 0.75
97 Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters. J Comput Assist Tomogr 2016 0.75
98 Comparison of intraarterial MR angiography at 3.0 T with X-ray digital subtraction angiography for detection of renal artery stenosis in swine. J Vasc Interv Radiol 2006 0.75
99 Renal artery stenosis in swine: feasibility of MR assessment of renal function during percutaneous transluminal angioplasty. Radiology 2007 0.75